Biosimilars Market - Global Industry Analysis and Forecast to 2020

Submitted by: Submitted by

Views: 33

Words: 753

Pages: 4

Category: Business and Industry

Date Submitted: 02/10/2015 09:16 PM

Report This Essay

Biosimilars Market - Global Industry Analysis and Forecast to 2020

Persistence Market Research

Biosimilars Market - Global Industry Analysis and Forecast to 2020

Persistence Market Research

1

Biosimilars Market - Global Industry Analysis and Forecast to 2020 Persistence Market Research Released New Market Report on “Biosimilars Market - Global Industry Analysis and Forecast to 2020”.

Biosimilars or follow-on biologics are biopharmaceutical drugs that are similar to approved biological drugs. Biosimilars are different from other generic drugs in terms of raw material and their manufacturing process. Generic drugs are composed of small molecules. However, biosimilars are composed of more complex molecules, such as human insulin and monoclonal antibodies. Many biosimilars are derived from plants, animals, bacteria, viruses and yeast. It is produced by recombinant DNA technology and controlled gene expression methods. Biosimilar drugs are used in prevention and treatment of various severe diseases such as cancer, diabetes, autoimmune diseases, heart attacks, rheumatoid arthritis, oncology, growth hormone deficiency, chronic kidney failure, hematological disease and infectious disease. Biosimilars offer less costly treatment than other biological drugs and synthetic drugs.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/biosimilarsmarket.asp

Europe is the largest market for biosimilars followed by North America and Asia-pacific. Asia-pacific is the fastest growing market for biosimilars due to low manufacturing cost, availability of skilled labor, less stringent regulatory environment and low manufacturing cost. Moreover, government associations are promoting the usage of biosimilars. For instance, in India, government provides various essential and regulatory guidelines for the usage of biosimilars products. In addition, low costs of biosimilars attract end users to adopt these products over synthetic and biological drugs in the Asian...